Patients undergoing cardiac surgery are significantly highly at risk of adverse outcomes due to comorbidities and aging[1].A previous study indicated that perioperative severe acute respiratory syndrome coronavirus 2(...Patients undergoing cardiac surgery are significantly highly at risk of adverse outcomes due to comorbidities and aging[1].A previous study indicated that perioperative severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection substantially increased postoperative morbidity and mortality[2].Despite the widespread vaccination efforts,cardiac surgery patients with a history of coronavirus disease 2019(COVID-19)remain vulnerable to reinfection due to the persistence of the virus in the body,even after respiratory viral detection test results return negative[3].展开更多
基金supported by the National Clinical Research Centre for Cardiovascular Diseases,Fuwai Hospital,Chinese Academy of Medical Sciences(NCRC2023001)。
文摘Patients undergoing cardiac surgery are significantly highly at risk of adverse outcomes due to comorbidities and aging[1].A previous study indicated that perioperative severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection substantially increased postoperative morbidity and mortality[2].Despite the widespread vaccination efforts,cardiac surgery patients with a history of coronavirus disease 2019(COVID-19)remain vulnerable to reinfection due to the persistence of the virus in the body,even after respiratory viral detection test results return negative[3].
